Similar results were obtained by in vivo experiments comparing Scr and sgTREX1 H69AR cells (Fig. 4F; Supplementary Fig. S4I), suggesting that cytoplasmic dsDNA degradation by TREX1 contributes to the survival and growth of cisplatin-resistant SCLC cells. This evidence concerns the gene TREX1 and small cell lung carcinoma.